- Home
- RICK vs FULC Comparison
RICK vs FULC Comparison
Compare RICK & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RICK
- FULC
- Stock Information
- Founded
- RICK 1983
- FULC 2015
- Country
- RICK United States
- FULC United States
- Employees
- RICK N/A
- FULC N/A
- Industry
- RICK Restaurants
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- RICK Consumer Discretionary
- FULC Health Care
- Exchange
- RICK Nasdaq
- FULC Nasdaq
- Market Cap
- RICK 361.6M
- FULC 372.2M
- IPO Year
- RICK 1995
- FULC 2019
- Fundamental
- Price
- RICK $37.21
- FULC $6.48
- Analyst Decision
- RICK Strong Buy
- FULC Buy
- Analyst Count
- RICK 1
- FULC 8
- Target Price
- RICK $98.00
- FULC $7.13
- AVG Volume (30 Days)
- RICK 80.9K
- FULC 477.2K
- Earning Date
- RICK 08-11-2025
- FULC 07-29-2025
- Dividend Yield
- RICK 0.75%
- FULC N/A
- EPS Growth
- RICK 252.84
- FULC N/A
- EPS
- RICK 1.86
- FULC N/A
- Revenue
- RICK $281,738,000.00
- FULC N/A
- Revenue This Year
- RICK $3.62
- FULC N/A
- Revenue Next Year
- RICK $8.86
- FULC N/A
- P/E Ratio
- RICK $20.08
- FULC N/A
- Revenue Growth
- RICK N/A
- FULC 2752.05
- 52 Week Low
- RICK $34.45
- FULC $2.32
- 52 Week High
- RICK $61.66
- FULC $9.30
- Technical
- Relative Strength Index (RSI)
- RICK 50.11
- FULC 43.58
- Support Level
- RICK $35.86
- FULC $6.35
- Resistance Level
- RICK $37.73
- FULC $6.85
- Average True Range (ATR)
- RICK 1.33
- FULC 0.32
- MACD
- RICK 0.19
- FULC 0.01
- Stochastic Oscillator
- RICK 72.63
- FULC 24.69
About RICK RCI Hospitality Holdings Inc.
RCI Hospitality Holdings Inc through its subsidiaries owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, dance fees, and room rentals.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.